Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0G4CI
|
|||
| Former ID |
DIB020342
|
|||
| Drug Name |
methylglyoxal
|
|||
| Synonyms |
pyruvaldehyde; pyruvic aldehyde; 2-Oxopropanal; acetylformaldehyde; 78-98-8; Acetylformyl; Propanal, 2-oxo-; 2-Ketopropionaldehyde; Propanedione; Propanolone; Pyroracemic aldehyde; Glyoxal, methyl; 2-Oxopropionaldehyde; alpha-Ketopropionaldehyde; 1-Ketopropionaldehyde; Propionaldehyde, 2-keto; Propionaldehyde, 2-oxo-; 1,2-Propanedione; Acetalformaldehyde; alpha-Ketopropionic aldehyde; 2-oxo-Propionaldehyde; CH3COCHO; FEMA No 2969; CCRIS 1741; 2-oxo-propanal; NSC 79019; NSC 626580; Pyruvoyl Group
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1], [2] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C3H4O2
|
|||
| Canonical SMILES |
CC(=O)C=O
|
|||
| InChI |
1S/C3H4O2/c1-3(5)2-4/h2H,1H3
|
|||
| InChIKey |
AIJULSRZWUXGPQ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 78-98-8
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
2945, 3827, 119143, 228444, 422484, 422485, 493005, 841795, 3137281, 5568782, 7890118, 8145726, 8150843, 10536063, 11528732, 15321021, 24439239, 24885071, 24896540, 24901425, 37336172, 46509036, 48414820, 50182604, 53790981, 56312073, 56313834, 56369729, 57288600, 57320562, 81044507, 85087720, 88811990, 92298545, 103429556, 104225911, 104296126, 104667741, 117359701, 117359702, 118980198, 124398000, 125374492, 126523848, 126678124, 127411153, 128506803, 128557784, 129252401, 134971237
|
|||
| ChEBI ID |
CHEBI:17158
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Phospholipase A2 (PLA2G1B) | Target Info | Inhibitor | [1] |
| Transformation-sensitive protein p120 (TRPA1) | Target Info | Activator | [3] | |
| BioCyc | Phospholipases | |||
| KEGG Pathway | Inflammatory mediator regulation of TRP channels | |||
| Glycerophospholipid metabolism | ||||
| Ether lipid metabolism | ||||
| Arachidonic acid metabolism | ||||
| Linoleic acid metabolism | ||||
| alpha-Linolenic acid metabolism | ||||
| Metabolic pathways | ||||
| Ras signaling pathway | ||||
| Vascular smooth muscle contraction | ||||
| Pancreatic secretion | ||||
| Fat digestion and absorption | ||||
| Pathway Interaction Database | Fc-epsilon receptor I signaling in mast cells | |||
| Reactome | TRP channels | |||
| Acyl chain remodelling of PC | ||||
| Acyl chain remodelling of PE | ||||
| Acyl chain remodelling of PI | ||||
| WikiPathways | Glycerophospholipid biosynthesis | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6. | |||
| REF 2 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6303). | |||
| REF 3 | Inhibiting TRPA1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals: sustained activation of the TRPA1 channel contributes to the pathogenesis of peripheral diabetic neuropathy. Pharmacol Res. 2012 Jan;65(1):149-58. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.